checkAd

    Theraclion  101  0 Kommentare Strong Commercial Progress in the First Half of 2018 - Seite 3

      june-18   june-17   Evolution   % Evolution
    Thyroid 327 168 159 95%
    Breast 81 63 18 29%
    Veins 36 36 NA
    Other   3   6   -3   -50%
    TOTAL   447   237   210   89%

    Number of treatments outside
    sponsored studies

    371 221 150 68%

    Finalization on June 5, 2018 of the study on the treatment of varicose veins by echotherapy

    Intermediate Outcomes: Safety and Effectiveness

    The study was conducted by Dr. Alfred Obermayer Vascular Surgeon at St. Joseph's Hospital in Vienna and Director of the Karl Landsteiner Institute for Functional Phlebology in Melk who states: "We are satisfied with the clinical results. We did echototherapy on patients who had already been treated with other techniques, without success. The encouraging results we have seen with echotherapy suggest that we have identified a relevant alternative to current solutions. "

    Benefits of echotherapy compared to existing methods

    Existing methods, even if some are minimally invasive, have disadvantages, mainly related to the fact that they require incisions: a sterile surgical block and anesthesia - or even a general anesthesia - are mandatory. These acts are delicate to perform, a large surgical experience is required, which makes them extremely dependent on the experience of operators. Side effects such as pigmentation, inflammation, nerve damage or induration are also sometimes observed. The patient who has just been treated is absolutely not autonomous and requires postoperative assistance. So many disadvantages that echotherapy is exonerated. This technique has the potential to respond to the shortcomings of existing methods.

    Seite 3 von 5




    Business Wire (engl.)
    0 Follower
    Autor folgen

    Theraclion Strong Commercial Progress in the First Half of 2018 - Seite 3 Regulatory News: THERACLION (Paris:ALTHE) (Euronext Growth, FR0010120402 – ALTHE), a company specialized in leading-edge medical equipment for echotherapy, announces today its sales for the first semester of 2018, …